Preparation of phenolic paclitaxel metabolites

Journal of Medicinal Chemistry

Volumn 39, Issue 14, 1996, Pages 2705-2709

  Park, Haeil ^a   Hepperle, Michael ^a   Boge, Thomas C ^a   Himes, Richard H ^a   Georg, Gunda I ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AZETIDINONE DERIVATIVE; 3' DEPHENYL 3' (4 HYDROXYPHENYL)PACLITAXEL; 7 (TRIETHYLSILYL)BACCATIN III; BACCATIN III; DRUG METABOLITE; N BENZOYL 2 AZETIDINONE; PACLITAXEL; PACLITAXEL DERIVATIVE; PHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; DRUG SYNTHESIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; MOLECULAR STRUCTURE; PACLITAXEL; PHENOL; PHENOLS; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0030004014     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960142x     Document Type: Article

References (31)

1. For review: Holmes, F. A.; Kudelka, A. P.; Kavanagh, J. J.; Huber, M. H.; Ajani, J. A.; Valero, V. Current Status of Clinical Trials with Paclitaxel and Docetaxel. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1995; Vol. 583, pp 31-57.
2. For review: Arbuck, S. G.; Blaylock, B. A. Taxol: Clinical Results and Current Issues in Development. In Taxol Science and Applications; Suffness, M., Ed.; CRC: Boca Raton, FL, 1995; pp 379-415.
3. For review: Manfredi, J. J.; Horwitz, S. B. Taxol: An Antimitotic Agent with a New Mechanism of Action. Pharmacol. Ther. 1984, 25, 83-124.
4. For review: Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1995; pp 460.
5. For review: Rowinsky, E. K.; Wright, M.; Monsarrat, B.; Lesser, G. J.; Donehower, R. C. Taxol: Pharmacology, Metabolism and Clinical Implications. Cancer Surveys 1993, 17, 283-304.
6. Vuilhorgne, M.; Gaillard, C.; Sanderink, G. J.; Royer, I.; Monsarrat, B.; Dubois, J.; Wright, M. Metabolism of Taxoid Drugs. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1995; pp 98-110.
7. Monsarrat, B.; Mariel, E.; Cros, S.; Garés, M.; Guénard, D.; Guéritte-Voegelein, F.; Wright, M. Isolation and Identification of Three Major Metabolites of Taxol in Rat Bile. Drug Metab. Dispos. 1990, 18, 895-901.
8. Walle, W.; Kumar, G. N.; McMillan, J. M.; Thornburg, K. R.; Walle, U. K. Taxol Metabolism in Rat Hepatocytes. Biochem. Pharmacol. 1993, 46, 1661-1664.
9. Walle, T.; Walle, U. K.; Kumar, G. N.; Bhalla, K. N. Taxol Metabolism and Disposition in Cancer Patients. Drug Metab. Dispos. 1995, 23, 506-512.
10. Harris, J. W.; Katki, A.; Anderson, L. W.; Chmurny, G. N.; Paukstelis, J. V.; Collins, J. M. Isolation, Structural Determination, and Biological Activity of 6-α-Hydroxytaxol, the Principle Human Metabolite of Taxol. J. Med. Chem. 1994, 37, 706-709.
11. Kumar, G. N.; Oatis, J. E., Jr.; Thornburg, K. R.; Heldrich, F. J.; Hazard, E. S., III; Walle, T. 6α-Hydroxytaxol: Isolation and Identification of the Major Metabolite of Taxol in Human Liver Microsomes. Drug Metab. Dispos. 1994, 22, 177-179.
12. Kumar, G. N.; Walle, U. K.; Walle, T. Cytochrome P450 3A-Mediated Human Liver Microsomal Taxol 6α-Hydroxylation. J. Pharmacol. Exp. Ther. 1994, 268, 1160-1165.
13. Cresteil, T.; Monsarrat, B.; Alvinerie, P.; Treluyer, J. M.; Vieira, I.; Wright, M. Taxol Metabolism by Human Liver Microsomes: Identification of Cytochrome P450 Isoenzymes Involved in Its Biotransformation. Cancer Res. 1994, 54, 386-392.
14. Harris, J. W.; Rahman, A.; Kim, B.-R.; Guengerich, F. P.; Collins, J. M. Metabolism of Taxol by Human Hepatic Microsomes and Liver Slices: Participation of Cytochrome P450 3A4 and an Unknown P450 Enzyme. Cancer Res. 1994, 54, 4026-4035.
15. Huizing, M. T.; Keung, A. C. F.; Rosing, H.; Van der Kuij, V.; ten Bokkel Huinink, W. W.; Mandjes, I. M.; Dubbelman, A. C.; Pinedo, H. L.; Beijnen, J. H. J. Clin. Oncol. 1993, 11, 2127.
16. Monegier, B.; Gaillard, C.; Sable, S.; Vuilhorgne, M. Structures of the Major Human Metabolites of Docetaxel (RP 56976 - Taxotere). Tetrahedron Lett. 1994, 35, 3715-3718.
17. Commerçon, A.; Bourzat, J. D.; Bezard, D.; Vuilhorgne, M. Partial Synthesis of Major Human Metabolites of Docetaxel. Tetrahedron 1994, 50, 10289-10298.
18. Georg, G. I.; Cheruvallath, Z. S.; Harriman, G. C. B.; Hepperle, M.; Park, H.; Himes, R. H. Synthesis and Biology of Substituted 3′-Phenyl Taxol Analogues. Bioorg. Med. Chem. Lett. 1994, 4, 2331-2336.
19. Georg, G. I.; Ali, S. M.; Boge, T. C.; Datta, A.; Falborg, L.; Park, H.; Mejillano, M.; Himes, R. H. Synthesis of Biologically Active 2-Benzoyl Paclitaxel Analogues. Bioorg. Med. Chem. Lett. 1995, 5, 259-264.
20. For a detailed procedure for the synthesis of 4, see: Georg, G. I.; Harriman, G. C. B.; Hepperle, M.; Clowers, J. S.; Vander Velde, D. G.; Himes, R. H. Synthesis, Conformational Analysis and Biological Evaluation of Heteroaromatic Taxanes. J. Org. Chem. 1996, 61, 2664-2676.
21. Ojima, I.; Habus, I.; Zhao, M.; Zucco, M.; Park, Y. H.; Sun, C. M.; Brigaud, T. New and Efficient Approaches to the Semisynthesis of Taxol and its C-13 Side Chain Analogs by Means of β-Lactam Synthon Method. Tetrahedron 1992, 48, 6985-7012.
22. Datta, A.; Jayasinghe, L. R.; Georg, G. I. Internal Nucleophile Assisted Selective Deesterification Studies on Baccatin III. Synthesis of 2-Debenzoyl- and 4-Deacetylbaccatin III Analogues. J. Org. Chem. 1994, 59, 4689-4690.
23. Georg, G. I.; Ali, S. M.; Boge, T. C.; Datta, A.; Falborg, L.; Himes, R. H. Selective C-2 and C-4 Deacylation and Acylation of Taxol: The First Synthesis of a C-4 Substituted Taxol Analogue. Tetrahedron Lett. 1994, 35, 8931-8934.
24. For review: Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Clowers, J. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. The Medicinal Chemistry of Taxol. In Taxol Science and Applications; Suffness, M., Ed.; CRC: Boca Raton, FL, 1995; pp 317-375.
25. For the synthesis of 3-(benzyloxy)benzoic acid from commercially available 3-(benzyloxy)benzaldehyde, see: Jones, B. The Halogenation of Phenolic Ethers and Anilides. Part XIV m-Substituted Phenyl Ethers. J. Chem. Soc. 1943, 430-432.
26. Ali, S. M.; Hoemann, M. Z.; Aubé, J.; Mitscher, L. A.; Georg, G. I.; McCall, R.; Jayasinghe, L. R. Novel Cytotoxic 3′-(tert-Butyl)-3-dephenyl Analogs of Paclitaxel and Docetaxel. J. Med. Chem. 1995, 38, 3821-3828.
27. Chaudhary, A. G.; Gharpure, M. M.; Rimoldi, J. M.; Chordia, M. D.; Gunatilaka, A. A. L.; Kingston, D. G. I.; Grover, S.; Lin, C. M.; Hamel, E. Unexpected Facile Hydrolysis of the 2-Benzoate Group of Taxol and Syntheses of Analogs with Increased Activities. J. Am. Chem. Soc. 1994, 116, 4097-4098.
28. Georg, G. I.; Cheruvallath, Z. S.; Himes, R. H.; Mejillano, M. R.; Burke, C. T. Synthesis of Biologically Active Taxol Analogues with Modified Phenylisoserine Side Chains. J. Med. Chem. 1992, 35, 4230-4237.
29. Sengupta, S.; Boge, T. C.; Georg, G. I.; Himes, R. H. Interaction of a Fluorescent Paclitaxel Analogue With Tubulin. Biochemistry 1995, 36, 11889-11894.
30. Colvin, E. W.; McGarry, D.; Nugent, M. J. Silicon-Assisted Synthesis of β-Lactams. Tetrahedron 1988, 44, 4157-4172.
31. Gassman, P. G.; Schenk, W. N. A General Procedure for the Base-Promoted Hydrolysis of Hindered Esters at Ambient Temperatures. J. Org. Chem. 1977, 42, 918-920.